Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 12/2017

04.10.2017 | Original Article

The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Surgical resection of extrahepatic biliary malignancies has been increasingly centralized at high-volume tertiary care centers. While this has improved outcomes overall, increased travel burden has been associated with worse survival for many other malignancies. We hypothesized that longer travel distances are associated with worse outcomes for these patients as well.

Study Design

Data was analyzed from the US Extrahepatic Biliary Consortium database, which retrospectively reviewed patients who received resection of extrahepatic biliary malignancies at 10 high-volume centers. Driving distance to the patient’s treatment center was measured for 1025 patients. These were divided into four quartiles for analysis: < 24.5, 24.5–57.2, 57.2–117, and < 117 mi. Cox proportional hazard models were then used to measure differences in overall survival.

Results

No difference was found between the groups in severity of disease or post-operative complications. The median overall survival in each quartile was as follows: 1st = 1.91, 2nd = 1.60, 3rd = 1.30, and 4th = 1.39 years. Patients in the 3rd and 4th quartile had a significantly lower median household income (p = 0.0001) and a greater proportion Caucasian race (p = 0.0001). However, neither of these was independently associated with overall survival. The two furthest quartiles were found to have decreased overall survival (HR = 1.39, CI = 1.12–1.73 and HR = 1.3, CI = 1.04–1.62), with quartile 3 remaining significant after multivariate analysis (HR = 1.45, CI = 1.04–2.0, p = 0.028).

Conclusions

Longer travel distances were associated with decreased overall survival, especially in the 3rd quartile of our study. Patients traveling longer distances also had a lower household income, suggesting that these patients have significant barriers to care.
Literatur
1.
Zurück zum Zitat Fong Y, Gonen M, Rubin D, Radzyner M, Brennan M; Long-Term Survival is Superior after Resection for Cancer in High- Volume centers. Ann Surg 2005;242:540–547PubMedPubMedCentral Fong Y, Gonen M, Rubin D, Radzyner M, Brennan M; Long-Term Survival is Superior after Resection for Cancer in High- Volume centers. Ann Surg 2005;242:540–547PubMedPubMedCentral
2.
Zurück zum Zitat Lidsky ME, Zhifei S, Nussbaum DP, Adam MA, Speicher PJ, Blazer DG; Going the extra mile Improved survival for Pancreatic cancer patients traveling to High-Volume Centers. Ann Surg. 2016; 20(10): 1–6 Lidsky ME, Zhifei S, Nussbaum DP, Adam MA, Speicher PJ, Blazer DG; Going the extra mile Improved survival for Pancreatic cancer patients traveling to High-Volume Centers. Ann Surg. 2016; 20(10): 1–6
3.
Zurück zum Zitat Aquina CT, Probst CP, Becerra AZ, Lannuzzi JC, Kelly KN, Hensley, BJ, Rickles AS, Noyes K, Fleming JF, Monson JR. High volume improved outcomes: The argument for centralization of rectal cancer surgery. Surgery 2016; 159(3): 736–48CrossRefPubMed Aquina CT, Probst CP, Becerra AZ, Lannuzzi JC, Kelly KN, Hensley, BJ, Rickles AS, Noyes K, Fleming JF, Monson JR. High volume improved outcomes: The argument for centralization of rectal cancer surgery. Surgery 2016; 159(3): 736–48CrossRefPubMed
4.
Zurück zum Zitat Stitzenberg KB, Sigurdson ER, Egleston BL, et al: Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 2009;27:4671–4678CrossRefPubMedPubMedCentral Stitzenberg KB, Sigurdson ER, Egleston BL, et al: Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol 2009;27:4671–4678CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Etzioni DA, Fowl RJ, Wasif N, Donohue JH, Cima RR; Distance Bias and Surgical Outcomes. Medical Care 2013; 51(3):238–244CrossRefPubMed Etzioni DA, Fowl RJ, Wasif N, Donohue JH, Cima RR; Distance Bias and Surgical Outcomes. Medical Care 2013; 51(3):238–244CrossRefPubMed
6.
Zurück zum Zitat Paltiel O, Ronen I, Polliack A, Epstein L. Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital. J Clin EpidemioI. 1998; 51:93–98CrossRef Paltiel O, Ronen I, Polliack A, Epstein L. Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital. J Clin EpidemioI. 1998; 51:93–98CrossRef
7.
Zurück zum Zitat Wasif N, Chang YH, Pockag BA, Gray RJ, Mathur A, Etzioni D; Association of Distance traveled for surgery with short and long- term Cancer Outcomes. Ann Surg Oncol 23:3444–3452 2016CrossRefPubMed Wasif N, Chang YH, Pockag BA, Gray RJ, Mathur A, Etzioni D; Association of Distance traveled for surgery with short and long- term Cancer Outcomes. Ann Surg Oncol 23:3444–3452 2016CrossRefPubMed
8.
Zurück zum Zitat Lamond EB, Hayreh D, Picket KE, Dignam JJ, List MA, Stenson KM, Haraf DJ, Brockstein BE, Sellergreen SA, Vokes EE; Is patient travel distance associated with survival on phase II clinical trials in oncology?. J Natl Cancer Inst. 2003; 95(18):1370–1375CrossRef Lamond EB, Hayreh D, Picket KE, Dignam JJ, List MA, Stenson KM, Haraf DJ, Brockstein BE, Sellergreen SA, Vokes EE; Is patient travel distance associated with survival on phase II clinical trials in oncology?. J Natl Cancer Inst. 2003; 95(18):1370–1375CrossRef
9.
Zurück zum Zitat Rodriguez CP, Jawde RA, Rybicki LA, Kalaycio ME, Advani A, Sobecks R, Sekeres MA. Impact of Socioeconomic status and Distance from treatment center on the survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res. 2008; 32(3):413–20CrossRefPubMed Rodriguez CP, Jawde RA, Rybicki LA, Kalaycio ME, Advani A, Sobecks R, Sekeres MA. Impact of Socioeconomic status and Distance from treatment center on the survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res. 2008; 32(3):413–20CrossRefPubMed
10.
Zurück zum Zitat Stitzenberg KB, Chang Y, Smith AB, Neilsen ME; Exploring the burden of Inpatient Readmissions after Major Cancer Surgery. J Clin Onco 2014;33:455–464CrossRef Stitzenberg KB, Chang Y, Smith AB, Neilsen ME; Exploring the burden of Inpatient Readmissions after Major Cancer Surgery. J Clin Onco 2014;33:455–464CrossRef
11.
Zurück zum Zitat Kneuertz PJ, Kao LS, Ko TC, Wray CJ; Regional disparities affected treatment and survival of patient with intrahepatic cholangiocarcinoma—a Texas Cancer Registry analysis. J Surg Oncol. 2014: 110(4):416–421CrossRefPubMed Kneuertz PJ, Kao LS, Ko TC, Wray CJ; Regional disparities affected treatment and survival of patient with intrahepatic cholangiocarcinoma—a Texas Cancer Registry analysis. J Surg Oncol. 2014: 110(4):416–421CrossRefPubMed
12.
13.
Zurück zum Zitat Proctor BD, Semega JL, Kollar MA. Income and poverty in the United States:2015. U.S. Census Bureau, Current Population Reports. 2016; 1–25 Proctor BD, Semega JL, Kollar MA. Income and poverty in the United States:2015. U.S. Census Bureau, Current Population Reports. 2016; 1–25
14.
Zurück zum Zitat Speicher PJ, Englum BR, Canapathi AM, Xiaofei W, Gartwig MC, D’Amico TA, Berry MF; Traveling to a High-Volume Center is associated with Improved Survival for Patients with Esophageal cancer. Ann Surg 256:743–749 2016; Speicher PJ, Englum BR, Canapathi AM, Xiaofei W, Gartwig MC, D’Amico TA, Berry MF; Traveling to a High-Volume Center is associated with Improved Survival for Patients with Esophageal cancer. Ann Surg 256:743–749 2016;
15.
Zurück zum Zitat Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a Barrier to cancer diagnosis and treatment: Review of the Literature. Oncologist. 2015. 20(2):1378–85CrossRefPubMedPubMedCentral Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a Barrier to cancer diagnosis and treatment: Review of the Literature. Oncologist. 2015. 20(2):1378–85CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Scoggins JF, Fedorenko CR, Donahue SM, Buchwald D, Blough DK, Ramsey SD. Is Distance to Provider a barrier to care for medicated patients with breast, colorectal, or lung cancer. J Rural Health. 2012. 28(1): 54–62CrossRefPubMed Scoggins JF, Fedorenko CR, Donahue SM, Buchwald D, Blough DK, Ramsey SD. Is Distance to Provider a barrier to care for medicated patients with breast, colorectal, or lung cancer. J Rural Health. 2012. 28(1): 54–62CrossRefPubMed
17.
Zurück zum Zitat Sharrocks K, Spicer J, Camidge DR, Papa S. The impact of socioeconomic status on access to cancer clinical trials. British Journal of Cancer. 2015. 111:1684–87CrossRef Sharrocks K, Spicer J, Camidge DR, Papa S. The impact of socioeconomic status on access to cancer clinical trials. British Journal of Cancer. 2015. 111:1684–87CrossRef
18.
Zurück zum Zitat Smith AK, Shara NM, Zeymo A, Harris K, Estes R, Johnson LB, Al-Refaie WB; Travel patterns of cancer surgery patients in a regionalized system. J Surg Res 199:97–105 2015CrossRefPubMed Smith AK, Shara NM, Zeymo A, Harris K, Estes R, Johnson LB, Al-Refaie WB; Travel patterns of cancer surgery patients in a regionalized system. J Surg Res 199:97–105 2015CrossRefPubMed
19.
Zurück zum Zitat Eli K, Vourlekis B, Xie B, Nedjat-Haiem FR, Lee PJ, Murderspach L, Russel C, Palinkas LA. Cancer treatment adherance among low-income women with breast or gynecologica cancer: a randomized controlled trial of patient navigation. Cancer. 2009. 115(19): 4606–15CrossRef Eli K, Vourlekis B, Xie B, Nedjat-Haiem FR, Lee PJ, Murderspach L, Russel C, Palinkas LA. Cancer treatment adherance among low-income women with breast or gynecologica cancer: a randomized controlled trial of patient navigation. Cancer. 2009. 115(19): 4606–15CrossRef
20.
Zurück zum Zitat Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raish P, Battaglia TA. J Clin Oncol. 2014. 32(25): 2758–64CrossRefPubMedPubMedCentral Ko NY, Darnell JS, Calhoun E, Freund KM, Wells KJ, Shapiro CL, Dudley DJ, Patierno SR, Fiscella K, Raish P, Battaglia TA. J Clin Oncol. 2014. 32(25): 2758–64CrossRefPubMedPubMedCentral
Metadaten
Titel
The Effects of Travel Burden on Outcomes After Resection of Extrahepatic Biliary Malignancies: Results from the US Extrahepatic Biliary Consortium
Publikationsdatum
04.10.2017
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 12/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3537-4

Weitere Artikel der Ausgabe 12/2017

Journal of Gastrointestinal Surgery 12/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.